10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $979,646 | -28.6% | 23,749 | -3.3% | 0.01% | -27.3% |
| Q2 2023 | $1,371,207 | +10.9% | 24,556 | +10.8% | 0.01% | 0.0% |
| Q1 2023 | $1,236,251 | +58.1% | 22,159 | +3.3% | 0.01% | +37.5% |
| Q4 2022 | $781,857 | +19.6% | 21,456 | -6.6% | 0.01% | +14.3% |
| Q3 2022 | $654,000 | -36.5% | 22,972 | +0.9% | 0.01% | -30.0% |
| Q2 2022 | $1,030,000 | -37.5% | 22,756 | +5.0% | 0.01% | -23.1% |
| Q1 2022 | $1,648,000 | -47.2% | 21,670 | +3.3% | 0.01% | -45.8% |
| Q4 2021 | $3,124,000 | +3.1% | 20,969 | +0.7% | 0.02% | -4.0% |
| Q3 2021 | $3,031,000 | -25.1% | 20,817 | +0.7% | 0.02% | -24.2% |
| Q2 2021 | $4,049,000 | +21.0% | 20,679 | +11.8% | 0.03% | +13.8% |
| Q1 2021 | $3,347,000 | +34.3% | 18,489 | +5.0% | 0.03% | +26.1% |
| Q4 2020 | $2,493,000 | – | 17,605 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |